To this end, we examined whether PTGS1 (COX-1), PTGS2 (COX-2), and PTGES3 can be used as independent predictors in the CRC patients’ outcome, using the TCGA-COAD and READ datasets. This evidence concerns the gene PTGS1 and colorectal carcinoma.